Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia — Neutral
KURA GlobeNewsWire — November 13, 2025– NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients – – Acute unmet need in R/R NPM1-mutated AML defined by historically poor outcomes and low survival rates at relapse – – FDA grants full approval of KOMZIFTI ahead of PDUFA target action date – – Approval is based on the KOMET-001 trial, in which KOMZIFTI demonstrated deep responses, a potentially best-in-class safety profile, once-daily administration, and ease of co-administration with common supportive medications in adult patients with R/R NPM1-mutated AML – – KOMZIFTI approval granted with no Boxed Warning related to QTc …
Tencent Music: Post-Earnings Price Correction Is Overdone — Negative
TME Seeking Alpha — November 13, 2025Tencent Music's stock price fell -8% following the results announcement, despite the fact that its Q3 topline and earnings exceeded expectations. TME's diversification into non-subscription businesses will boost revenue stability, even though it came at the expense of a gross margin decline in the recent quarter. Competitive concerns from ByteDance's Soda Music are overblown, as TME has a differentiated user base.
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
INSP GlobeNewsWire — November 13, 2025LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.
Walt Disney (NYSE: DIS) shares are down 8% on Thursday, November 13, following mixed fourth-quarter results.
Geopolitics are weighing on oil and gas, but broker sees gold price as high as $5,000 in 2026 — Negative
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Proactive Investors — November 13, 2025Geopolitical risks and freight pressures are weighing on commodity markets, highlight analysts at RBC Capital Markets, with early compliance to incoming US sanctions on Russian oil producers already disrupting operations in Iraq. Analysts at the Canadian bank reckon companies are “complying in advance” of a 21 November start date for US sanctions, with Lukoil facing funding blocks and cargo allocation withdrawals at the West Qurna-2 field.
Here's Why Central Garden (CENT) is a Strong Growth Stock — Positive
CENT Zacks Investment Research — November 13, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Dropbox (DBX) is a Top-Ranked Growth Stock: Should You Buy? — Positive
DBX Zacks Investment Research — November 13, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Star Equity Holdings (STRR) Q3 Earnings Miss Estimates — Negative
STRR Zacks Investment Research — November 13, 2025Star Equity Holdings (STRR) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to a loss of $0.13 per share a year ago.
Why GSK (GSK) is a Top Growth Stock for the Long-Term — Positive
GSK Zacks Investment Research — November 13, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why LATAM (LTM) is a Strong Growth Stock — Positive
LTM Zacks Investment Research — November 13, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Nutanix (NTNX) is a Strong Growth Stock — Positive
NTNX Zacks Investment Research — November 13, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Equifax (EFX) is a Top Growth Stock for the Long-Term — Positive
EFX Zacks Investment Research — November 13, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Pegasystems (PEGA) is a Top Growth Stock for the Long-Term — Positive
PEGA Zacks Investment Research — November 13, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Workday (WDAY) is a Top Growth Stock for the Long-Term — Positive
WDAY Zacks Investment Research — November 13, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why W.R. Berkley (WRB) is a Top Growth Stock for the Long-Term — Positive
WRB Zacks Investment Research — November 13, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term — Positive
PAHC Zacks Investment Research — November 13, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Strategy's Michael Saylor is still bullish on bitcoin investing despite recent pullback — Positive
MSTR Yahoo Finance — November 13, 2025Bitcoin (BTC-USD) continues to pull back since hitting its record high above $126,000 in early October. How should investors be feeling about the latest turbulence for this crypto asset staple?
Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock — Positive
BMY Zacks Investment Research — November 13, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Value Investors Buy First Financial Ban (FFBC) Stock? — Positive
FFBC Zacks Investment Research — November 13, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Cencora (COR) is a Top Value Stock for the Long-Term — Positive
COR Zacks Investment Research — November 13, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
